Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-10-020966
Filing Date
2010-04-08
Accepted
2010-04-08 16:55:54
Documents
1
Period of Report
2010-04-08

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES rrd272439.html 4/A  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES rrd272439.xml 4/A 3478
  Complete submission text file 0001181431-10-020966.txt   5279
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O IMMUCELL CORP 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address
ROTHSCHILD JONATHAN E (Reporting) CIK: 0001043218 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-12934 | Film No.: 10740237